학술논문
Oral decitabine plus cedazuridine and venetoclax in patients with higher-risk myelodysplastic syndromes or chronic myelomonocytic leukaemia: a single-centre, phase 1/2 study
Document Type
Article
Author
Bataller, A.; Montalban-Bravo, G.; Bazinet, A.; Alvarado, Y.; Chien, K.; Ishizawa, J.; Hammond, D.; Swaminathan, M.; Sasaki, K.; Issa, G.C.; Short, N.J.; Masarova, L.; Daver, N.G.; Kadia, T.M.; Colla, S.; Hendrickson, S.; Ravandi, F.; Jabbour, E.; Kantarjian, H.; Garcia-Manero, G.; Qiao, W.; Huang, X.; Kanagal-Shamanna, R.; Venugopal, S.
Source
In: The Lancet Haematology . (The Lancet Haematology, March 2024, 11(3):e186-e195)
Subject
Language
English
ISSN
23523026